Wenshuo Zhou earned a PhD in biomedical sciences from Old Dominion University in 2020. Then, he joined the US Food and Drug Administration as an ORISE postdoc fellow (3 years). He is now the leading scientist and CSO academic secretary at CNBG-Virogin, which is an mRNA vaccine company. His work in infectious disease, exosomes, and vaccines has resulted in dozens of publications, patents, and lectures. His research interests include arthropod-borne virus (DENV, LGTV, WNV, ZIKV, rickettsia, etc.) transmission facilitated by exosomes and preclinical mRNA vaccine studies.